绿叶制药控股股东增持200万股 持股比例增至总股本的33.53%
财中社12月18日电绿叶制药（02186）发布自愿性公告，控股股东于2024年12月18日增持本公司股权。执行董事兼执行主席刘殿波通过其受控法团绿叶制药投资有限公司，在市场内购入200万股普通股，平均购入价为每股约2.2299港元。购入后，刘殿波持有本公司12.61亿股股份，权益占本公司已发行股本总额约33.53%。
刘殿波对公司的增长、发展及未来前景表示充满信心，并可能在适当时机进一步增加其持股比例。公告提醒股东及潜在投资者在买卖公司证券时需谨慎行事。
（文章来源：财中社）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Most Discussed
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10